Division of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Hospital of the University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA, 19104, USA.
AIDS Behav. 2023 Oct;27(10):3460-3467. doi: 10.1007/s10461-023-04060-w. Epub 2023 Apr 10.
Despite evidence supporting HIV pre-exposure prophylaxis (PrEP) effectiveness, very few women with opioid use disorder (OUD) take PrEP. Interventions that improve medication assisted treatment (MAT) uptake and adherence may also be beneficial for PrEP. The reSET-O mobile phone app is a component of the evidence-based Therapeutic Education System, which improves retention and abstinence for people with OUD. To better understand use of this mobile health tool as a support for PrEP among women with OUD, pre-implementation contextual inquiry is needed. Therefore, we set out to assess target user characteristics, implementation barriers, feasibility, and acceptability of reSET-O. We recruited women with OUD receiving care from a community-based organization in Philadelphia to complete semi-structured interviews. All participants were prescribed reSET-O. We interviewed 20 participants (average age 37 years; 70% white, 15% Hispanic, 5% Black) from 5/2021 to 2/2022. We used an integrated analysis approach combining modified grounded theory and implementation science constructs. Half reported recent injection drug use, and 6 were taking buprenorphine. Mental health symptoms were common, and half described engaging in transactional sex. The majority expressed strong interest in PrEP. Participants reported the app would be highly acceptable for PrEP and MAT adherence support, but only two redeemed the prescription. The most common barriers included phone and internet access. Our findings highlight potential implementation challenges for the use of such an app to support PrEP use in this population. Poor uptake of the app at follow-up indicates that initial prescription redemption is a major barrier to reSET-O implementation.
尽管有证据支持艾滋病毒暴露前预防 (PrEP) 的有效性,但很少有患有阿片类药物使用障碍 (OUD) 的女性使用 PrEP。改善药物辅助治疗 (MAT) 使用率和依从性的干预措施也可能对 PrEP 有益。reSET-O 手机应用程序是循证治疗教育系统的一个组成部分,该系统可提高 OUD 患者的保留率和戒断率。为了更好地了解将这种移动健康工具作为 OUD 女性 PrEP 的支持手段的使用情况,需要在实施前进行背景调查。因此,我们着手评估 reSET-O 在患有 OUD 的女性中的目标用户特征、实施障碍、可行性和可接受性。我们招募了正在费城一家社区组织接受治疗的患有 OUD 的女性,让她们完成半结构化访谈。所有参与者都被开了 reSET-O。我们于 2021 年 5 月至 2022 年 2 月间采访了 20 名参与者(平均年龄 37 岁;70%为白人,15%为西班牙裔,5%为黑人)。我们使用了一种综合分析方法,结合了改良的扎根理论和实施科学结构。其中一半人报告最近有注射吸毒行为,6 人正在服用丁丙诺啡。常见的心理健康症状,且一半人表示从事过交易性性行为。大多数人对 PrEP 表现出浓厚的兴趣。参与者表示,该应用程序将非常适合 PrEP 和 MAT 依从性支持,但只有两人兑现了处方。最常见的障碍包括手机和互联网接入。我们的研究结果突显了在该人群中使用此类应用程序支持 PrEP 使用的潜在实施挑战。在随访中 reSET-O 的使用率很低,这表明初始处方兑现是 reSET-O 实施的一个主要障碍。